WELLESLEY HILLS, Mass., Oct. 12 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that he is offering for sale the patented technology to integrate germanium photodetectors with silicon circuits at the November 5, 2010 sealed bid sale of NoblePeak Vision Corp. assets.
NoblePeak has developed and implemented a process flow that incorporates single crystal germanium photodetectors with CMOS circuits. By taking advantage of germanium's sensitivity to longer wavelengths, TriWave reaches past the near-infrared spectrum into the SWIR. These wavelengths are beyond what silicon-based low light CMOS and CCD cameras can see. Subsequently, illumination from the Earth's natural Night Glow is now visible and can be utilized to build high-resolution, high performance day/night cameras at commercial prices.
The intellectual property, fixed assets and inventory will be sold by a sealed bid sale at 12:00 noon on November 5, 2010.
Persons interested in bidding must sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's Office – email@example.com or 781-237-8840. They will then receive a bid package.
About Joseph F. Finn, Jr., C.P.A.
Joseph F. Finn, Jr., C.P.A. is the owner of the firm Finn, Warnke & Gayton, Certified Public Accountants of Wellesley Hills, Massachusetts. He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as assignee for the benefit of creditors and liquidating agent for a corporation. He has been involved in a number of loan workouts and bankruptcy cases for thirty-five (35) years. His most recent Assignments for the Benefit of Creditors in the biotech field include Spherics, Inc., ActivBiotics, Inc., Prospect Therapeutics, Inc. and Epix Pharmaceuticals, Inc.
For further information, please contact Joseph F. Finn, Jr., C.P.A. at 781-237-8840 or firstname.lastname@example.org
SOURCE Joseph F. Finn, Jr., C.P.A.